TidalSense has raised $18.8M to keep building out its AI-driven respiratory diagnostics, the Cambridge, UK company confirmed.
TidalSense - formerly Cambridge Respiratory Innovations - is built around its patented N-Tidal sensor, which measures CO2 at high accuracy and rapid sampling to give clinicians a detailed read on lung physiology. The company says the insight it provides is unlike anything currently available in clinical medicine.













